Buscar
01/03/2026
The current landscape of single-port robotic surgery in urology
Biasatti, A, Soputro, NA, Porpiglia, F, Perdonà, S, Abdollah, F, Nelson, R, Rogers, C, Zhao, LC, Ghazi, A, Challacombe, B, Eden, C, Mattei, A, Fankhauser, CD, Breda, A, Rocco, B, Montorsi, F, Briganti, A, Pellegrino, AA, Mottrie, A, De Groote, R, Haese, A, Graefen, M, Moschovas, MC, Patel, V, Simone, G, Galfano, A, Secco, S, Bertolo, R, Pandolfo, SD, Pansadoro, V, Carvalho, FLF, Joseph, JV, Ramadan, M, Shakuri-Rad, J, Yuh, B, Nix, J, Lee, DI, Rais-Bahrami, S, Hemal, S, Eltemamy, M, Beksac, AT, Schwen, Z, Su, LM, Buscarini, M, Palese, M, Tewari, A, Wiklund, P, Cherullo, EE, Vourganti, S, Linehan, JA, Wu, ZJ, Stifelman, M, Ahmed, M, Mehrazin, R, Badani, K, Link, RE, Crivellaro, S, Kaouk, J, Autorino, R. The current landscape of single-port robotic surgery in urology. Nature Reviews Urology. 2026; 23(3)DOI:10.1038/s41585-025-01081-z. PMID:40897917. IF:14.600(Q1/1D).
01/03/2026
Improving long-term monitoring in NMIBC: Digital Uromonitor® as a complementary tool to cystoscopy for predicting two-year recurrence (Evaluation-Cueto study)
Briones, JR, Ramos, FG, Sánchez, AM, Abadia, IB, Rodríguez, RM, Alcaraz, A, Legaz, MM, Lozano, F, Martín, MA, Cardo, AL, Rodríguez, VG, Velasco, JC, Liesa, MS, Pareja, CF, Ortiz, RE, de Torres, IGV, Zalabardo, DS, Guijarro, A, Mengual, L, Borque-Fernando, A, Escano, LME, Redorta, JP, Witjes, F, Pineiro, LM. Improving long-term monitoring in NMIBC: Digital Uromonitor® as a complementary tool to cystoscopy for predicting two-year recurrence (Evaluation-Cueto study). EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2026
Impact of ischaemia duration and clamping strategy in patients with solitary kidney undergoing partial nephrectomy
Cei, F, Cignoli, D, Franco, I, Rha, KH, Wagner, C, Kutikov, A, Porter, J, Challacombe, B, Badani, K, Roussel, E, Bertolo, R, Antonelli, A, Schiavina, R, Barretta, A, Bensalah, K, Zhang, X, Derweesh, I, De Groote, R, De Naeyer, G, Mottrie, A, Breda, A, Minervini, A, Campi, R, Salonia, A, Briganti, A, Montorsi, F, Capitanio, U, Larcher, A. Impact of ischaemia duration and clamping strategy in patients with solitary kidney undergoing partial nephrectomy. BJU INTERNATIONAL. 2026; 137(3)DOI:10.1111/bju.70146. PMID:41528060. IF:4.400(Q1/2D).
01/03/2026
A proposal of EAU-YAU trifecta score for upper tract urothelial patients treated with endoscopic kidney sparing approach
Di Bello, F, Andrea, G, Zattoni, F, Laukhtina, E, D'Andrea, D, Soria, F, Afferi, L, Del Giudice, F, Krajewski, W, Marcq, G, De Lorenzis, E, Moschini, M, Mari, A, Subiela, JD, Dieguez, L, Izquierdo, P, Chung, B, Pradere, B, Avesani, G, Belarmino, A, Territo, A, Palou, J, Breda, A. A proposal of EAU-YAU trifecta score for upper tract urothelial patients treated with endoscopic kidney sparing approach. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2026
Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancer
Uleri, A, Baboudjian, M, Leni, R, Oderda, M, Peyrottes, A, Kesch, C, Al-Nader, M, Dariane, C, Baud, H, Olivier, J, Rios, AR, Sanguedolce, F, Benard, V, Windisch, O, Valerio, M, Gandaglia, G, Ploussard, G. Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancer. PROSTATE CANCER AND PROSTATIC DISEASES. 2026; 29(1)DOI:10.1038/s41391-025-00977-6. PMID:40301553. IF:5.800(Q1/1D).
01/03/2026
International Delphi consensus on UTUC management: The IMPACT UTUC project
Pandolfo, SD, Contieri, R, Catto, J, Briganti, A, Roupret, M, Pradere, B, Porpiglia, F, Amparore, D, Minervini, A, Bertolo, R, Moschini, M, Mertens, L, Rhijn, BWGV, Gallioli, A, Formisano, L, Imbimbo, C, Lucarelli, G, Ferro, M, Gupta, S, Mir, MC, Derweesh,, Djaladat, H, Bukavina, L, Autorino, R. International Delphi consensus on UTUC management: The IMPACT UTUC project. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders
Bolsewig, K, Bellomo, G, Hok-A-Hin, YS, Al Idrissi, I, Vermunt, L, Lleó, A, Alcolea, D, Sieben, A, Engelborghs, S, Simonsen, AH, Hasselbalch, SG, Bech, S, Morrema, THJ, Hoozemans, JJM, Bol, JGJM, Van Alphen, J, Gaetani, L, Chiasserini, D, Paoletti, FP, Parnetti, L, Kang, SW, Lee, YG, Jeon, S, Lee, AH, Jeon, S, Ye, BS, Milán, MD, Van Der Flier, WM, Van De Berg, WDJ, Lemstra, AW, Willemse, EAJ, Teunissen, CE. A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders. NATURE MEDICINE. 2026; 32(3)DOI:10.1038/s41591-026-04212-0. PMID:41699128. IF:50.000(Q1/1D).
01/03/2026
Neoadjuvant radiotherapy for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis
Fairweather, M, Sulciner, M, Jolissaint, JS, Fiore, M, Ortega, DYG, Iwata, S, Ford, SJ, Swallow, C, Nizri, E, Quagliuolo, V, Nessim, C, Adamkova, D, Rutkowski, P, Cardona, K, Kim, E, Porpiglia, AS, Johnston, FM, Gyorki, DE, Vincenzi, B, Corina, KF, Kramer, S, Blazer, D, Tseng, WW, Albertsmeier, M, González, JA, Hompes, D, Baldini, EH, Gronchi, A, Rauta, CP. Neoadjuvant radiotherapy for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis. Eclinicalmedicine. 2026; 93DOI:10.1016/j.eclinm.2026.103805. PMID:41783086. IF:10.000(Q1/1D).